Omnes hits fundraising trail for Croissance 5 fund

Unquote previously reported that the launch of Croissance 5 was planned for H2 2020. The fund is now on the road, with a first close expected between Q4 and Q1 next year, Omnes managing partner Benjamin Arm told Unquote.

Omnes is also raising capital for its vehicles focusing on the smaller end of the market, including the Omnes Expansion 3 and LCL Expansion 3 funds.

Omnes has increased its focus on ESG recently with a dedicated ESG strategic committee headed by Corinne Lepage, a former European MP and former French minister for the environment, and the establishment of a climate "risks and opportunities" matrix, Arm said.

Investments
Omnes' Croissance funds focus on the mid-market buyout and growth capital segments in France.

The fourth-generation vehicle, which held a €210m final close in late 2016, targets French SMEs with turnovers in the €25-180m range, investing equity tickets of €8-25m. Portfolio companies of Omnes Croissance 4 include BioFutur, Captain Tortue, Intys Consulting and Spherea, among others.

The strategy will remain very similar for Croissance 5, although the larger target size will enable Omnes to deploy larger tickets: the fund will target primarily French SMEs with enterprise values in the €75-150m range, investing equity tickets of €30-40m, according to Arm.

People
Omnes Capital – Benjamin Arm (managing partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Buyout
• France
• GPs
• Omnes Capital